BRANDHIT MARKETING SUMMIT: A HIMSS EVENT
Nashville, TN - MAY 7 - 8, 2018
Lynn Hanessian is the chief strategist for Edelman. In her position, she brings together industry, content, and media expertise to craft campaigns to achieve the business objectives of her clients. Her focus in on health and science engagement initiatives reaching a wide range of audiences. She also supports efforts addressing market access priorities for clients in the US, ensuring integration and coordination across marketing, communications and policy initiatives. Thought leader engagement and advocacy counsel are core components of these efforts.
Lynn has a deep background in health, medical and science strategic positioning, and communication working with health systems, pharmaceutical and device companies, medical societies and patient advocacy groups. Lynn has led regional, national and global teams providing support to pharmaceutical and medical products at all stages of the product life cycle. She has also been actively involved in marketing, communications, advocacy relations, professional society engagement, corporate positioning programs and crisis communications efforts. Lynn has worked on a wide range of therapeutic areas including infectious diseases, CNS, allergic diseases, oncology and metabolic diseases.
Lynn’s background includes expertise in corporate and foundation relations, medical associations, philanthropy, fund raising, and children’s issues. Prior to Edelman, she held positions at the American Academy of Pediatrics where she built strategic corporate alliances, cultivated and solicited major grants, and developed a wide range of programs for healthcare provider and consumer audiences.
She earned an AB in economics from the University of Chicago.
Lynn Hanessian, chief strategist at Edelman, will share proprietary research on the state of trust in Health from Edelman’s 2018 Trust Barometer, the firm’s 18th annual trust and credibility survey sampling more than 33,000 respondents across 28 markets. This year’s data emphasize the importance of societally-focused behaviors in addition to operational competency, and shed new light on consumer media habits and trust in the information provided by a variety of sources. Maintaining and increasing trust means health leaders must continue – and enhance – operating with transparency, acting like media companies, activating a wide array of champions to tell their story and having a deep understanding of the perceptions of consumers. New data address consumer perceptions of innovation, who is to blame for the high cost of healthcare and expectations of the impact of Health Technology on the delivery of healthcare.